US pharma giant Pfizer on Saturday announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...
Data from the first in human study on O3R-5671’s potent TNFα inhibition to be presented Dosing of the final cohort in the first in human study has been initiated Studies in ulcerative colitis and ...
FemPulse™, a bioelectronic medical technology company with first application overactive bladder, announced today that an ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
When the iPhone debuted, critics said thumbs couldn’t type on glass. Steve Jobs disagreed. People did learn. But with tech ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
On December 11, 2025, TheFly reported that Citizens boosted its price goal for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) to ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage ...
ITWeb on MSN
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA
A Potential New Standard for First-Line HER2+ Advanced GEA* Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status* High GEA burden ...
Futurism on MSN
Woman Hacks “Tinder for Nazis,” Tricks the Racist Users Into Falling in Love With AI Chatbots
"Show interest in traditional family roles and heritage, using an approachable tone with a mix of warmth and conviction." ...
The project, spearheaded by the Schlesinger family, would see a 29-unit complex replaced by a 12-unit Venetian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback